<?xml version='1.0' encoding='UTF-8'?><?xml-stylesheet href="http://www.blogger.com/styles/atom.css" type="text/css"?><feed xmlns='http://www.w3.org/2005/Atom' xmlns:openSearch='http://a9.com/-/spec/opensearchrss/1.0/' xmlns:georss='http://www.georss.org/georss' xmlns:gd='http://schemas.google.com/g/2005' xmlns:thr='http://purl.org/syndication/thread/1.0'><id>tag:blogger.com,1999:blog-27204255</id><updated>2011-12-18T21:42:05.167-08:00</updated><title type='text'>Neurology Updates</title><subtitle type='html'></subtitle><link rel='http://schemas.google.com/g/2005#feed' type='application/atom+xml' href='http://neurology-healthcare.blogspot.com/feeds/posts/default'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default?max-results=100'/><link rel='alternate' type='text/html' href='http://neurology-healthcare.blogspot.com/'/><link rel='hub' href='http://pubsubhubbub.appspot.com/'/><author><name>my-healthcare</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><generator version='7.00' uri='http://www.blogger.com'>Blogger</generator><openSearch:totalResults>62</openSearch:totalResults><openSearch:startIndex>1</openSearch:startIndex><openSearch:itemsPerPage>100</openSearch:itemsPerPage><entry><id>tag:blogger.com,1999:blog-27204255.post-115996458800654261</id><published>2006-11-14T17:16:00.000-08:00</published><updated>2006-11-15T01:01:46.626-08:00</updated><title type='text'>Anesthetic Considerations for Magnetic Seizure Therapy: A Novel Therapy for Severe Depression.</title><summary type='text'>In an effort to find safer and more effective alternatives to antidepressant drugs for treating severe depression, investigators have recently examined a variety of nonpharmacologic modalities (e.g., modified electroconvulsive therapy [ECT], repetitive transcranial magnetic stimulation [rTMS], and magnetic seizure therapy [MST]). Although ECT is highly effective, its use is limited by adverse </summary><link rel='replies' type='application/atom+xml' href='http://neurology-healthcare.blogspot.com/feeds/115996458800654261/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=27204255&amp;postID=115996458800654261' title='23 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/115996458800654261'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/115996458800654261'/><link rel='alternate' type='text/html' href='http://neurology-healthcare.blogspot.com/2006/11/anesthetic-considerations-for-magnetic.html' title='Anesthetic Considerations for Magnetic Seizure Therapy: A Novel Therapy for Severe Depression.'/><author><name>my-healthcare</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>23</thr:total></entry><entry><id>tag:blogger.com,1999:blog-27204255.post-115996415381569488</id><published>2006-10-29T17:06:00.000-08:00</published><updated>2006-10-30T08:16:01.700-08:00</updated><title type='text'>Seizures associated with solitary cysticercus granuloma: Antiepileptic drugs for how long?.</title><summary type='text'>In human brain parenchyma, the larval form of Taenia solium undergoes four stages of evolution, vesicular, colloidal, granular-nodular and calcification. The term, cysticercus granuloma is used broadly to parasites in the colloidal or the granular-nodular stages and these two stages are together considered as transitional or degenerative phase of the disease process.Seizures associated with </summary><link rel='replies' type='application/atom+xml' href='http://neurology-healthcare.blogspot.com/feeds/115996415381569488/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=27204255&amp;postID=115996415381569488' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/115996415381569488'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/115996415381569488'/><link rel='alternate' type='text/html' href='http://neurology-healthcare.blogspot.com/2006/10/seizures-associated-with-solitary.html' title='Seizures associated with solitary cysticercus granuloma: Antiepileptic drugs for how long?.'/><author><name>my-healthcare</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-27204255.post-115996329268773984</id><published>2006-10-24T16:50:00.000-07:00</published><updated>2006-10-25T07:14:27.873-07:00</updated><title type='text'>Safety and efficacy of clobazam versus phenytoin-sodium in the antiepileptic drug treatment of solitary cysticercus granulomas.</title><summary type='text'>Single enhancing lesions (SELs) are commonly noted upon imaging studies of young persons with new-onset seizures in several neurocysticercosis-endemic geographic regions. The lesions are believed to represent involuting solitary cysticercus granulomas (SCGs). Treatment policies vary between administration of antiepileptic drugs (AEDs) alone or in combination with a course of anthelminthic agents.</summary><link rel='replies' type='application/atom+xml' href='http://neurology-healthcare.blogspot.com/feeds/115996329268773984/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=27204255&amp;postID=115996329268773984' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/115996329268773984'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/115996329268773984'/><link rel='alternate' type='text/html' href='http://neurology-healthcare.blogspot.com/2006/10/safety-and-efficacy-of-clobazam-versus.html' title='Safety and efficacy of clobazam versus phenytoin-sodium in the antiepileptic drug treatment of solitary cysticercus granulomas.'/><author><name>my-healthcare</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-27204255.post-115995985861811223</id><published>2006-10-17T15:58:00.000-07:00</published><updated>2006-10-18T07:58:58.826-07:00</updated><title type='text'>Electroclinical features of absence seizures in childhood absence epilepsy.</title><summary type='text'>Childhood absence epilepsy (CAE) is defined by frequent daily absence seizures in normal school age children with EEG features of bilateral synchronous symmetric 3-Hz spike-wave and normal background activity. CAE accounts for 8 to 15% of all childhood epilepsies, with an annual incidence of 4.7 to 8.0 per 100,000 children between the ages of 1 and 15 years. Generalized tonic-clonic seizures </summary><link rel='replies' type='application/atom+xml' href='http://neurology-healthcare.blogspot.com/feeds/115995985861811223/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=27204255&amp;postID=115995985861811223' title='3 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/115995985861811223'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/115995985861811223'/><link rel='alternate' type='text/html' href='http://neurology-healthcare.blogspot.com/2006/10/electroclinical-features-of-absence.html' title='Electroclinical features of absence seizures in childhood absence epilepsy.'/><author><name>my-healthcare</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>3</thr:total></entry><entry><id>tag:blogger.com,1999:blog-27204255.post-115995952046096118</id><published>2006-10-15T13:54:00.000-07:00</published><updated>2006-10-15T10:39:02.090-07:00</updated><title type='text'>Nonconvulsive Seizures in Electroconvulsive Therapy.</title><summary type='text'>Further Evidence of Differential Neurophysiological Aspects of Bitemporal Versus Bifrontal Electrode Placement.Early studies of electrode placement in electroconvulsive therapy (ECT) practice focused on bitemporal and unilateral placements. In 1968, Inglis proposed a method for reducing both verbal and nonverbal memory impairment by sparing electrical stimulation to either temporal lobe. </summary><link rel='replies' type='application/atom+xml' href='http://neurology-healthcare.blogspot.com/feeds/115995952046096118/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=27204255&amp;postID=115995952046096118' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/115995952046096118'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/115995952046096118'/><link rel='alternate' type='text/html' href='http://neurology-healthcare.blogspot.com/2006/10/nonconvulsive-seizures-in.html' title='Nonconvulsive Seizures in Electroconvulsive Therapy.'/><author><name>my-healthcare</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-27204255.post-115995925630913714</id><published>2006-10-11T08:48:00.000-07:00</published><updated>2006-10-11T10:03:49.316-07:00</updated><title type='text'>Electroconvulsive Therapy Stimulus Dose Expressed as Volume of Seizure Foci.</title><summary type='text'>Expressing the electroconvulsive therapy (ECT) electrical stimulus dose as the electrical charge (in millicoulombs [mC]) alone overlooks the effect of voltage difference on the ability of the stimulus to induce a convulsion. The charge represents the number of electrons in the stimulus, failing to distinguish between delivering the charge rapidly (with high voltage difference) or slowly, but the </summary><link rel='replies' type='application/atom+xml' href='http://neurology-healthcare.blogspot.com/feeds/115995925630913714/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=27204255&amp;postID=115995925630913714' title='1 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/115995925630913714'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/115995925630913714'/><link rel='alternate' type='text/html' href='http://neurology-healthcare.blogspot.com/2006/10/electroconvulsive-therapy-stimulus.html' title='Electroconvulsive Therapy Stimulus Dose Expressed as Volume of Seizure Foci.'/><author><name>my-healthcare</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>1</thr:total></entry><entry><id>tag:blogger.com,1999:blog-27204255.post-115995891128105268</id><published>2006-10-08T15:42:00.000-07:00</published><updated>2006-10-09T05:53:56.753-07:00</updated><title type='text'>Structural changes in patients with primary generalized tonic and clonic seizures.</title><summary type='text'>According to the International Classification of Epilepsies, idiopathic generalized epilepsy (IGE) is characterized by absence of cerebral abnormalities. However, this is contradicted by findings of migrational disturbances, cerebral distortions, and neuroreceptor and metabolite changes in IGE.In the current study, we investigated whether IGE is associated with structural changes and whether the </summary><link rel='replies' type='application/atom+xml' href='http://neurology-healthcare.blogspot.com/feeds/115995891128105268/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=27204255&amp;postID=115995891128105268' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/115995891128105268'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/115995891128105268'/><link rel='alternate' type='text/html' href='http://neurology-healthcare.blogspot.com/2006/10/structural-changes-in-patients-with.html' title='Structural changes in patients with primary generalized tonic and clonic seizures.'/><author><name>my-healthcare</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-27204255.post-115935548448823215</id><published>2006-10-04T15:54:00.000-07:00</published><updated>2006-10-05T06:34:58.593-07:00</updated><title type='text'>Presentation, Natural History, and Management of Carotid Cavernous Aneurysms.</title><summary type='text'>Although the risk of life-threatening or permanent neurological complications from carotid cavernous aneurysms (CCA) is low, neuro-ophthalmic morbidity and pain caused by CCAs are common and often lead to consideration of treatment. To assess the potential benefits of treatment of CCAs, one has to examine not only the outcome of treatment, as did the analysis by van der Schaaf et al., but also </summary><link rel='replies' type='application/atom+xml' href='http://neurology-healthcare.blogspot.com/feeds/115935548448823215/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=27204255&amp;postID=115935548448823215' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/115935548448823215'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/115935548448823215'/><link rel='alternate' type='text/html' href='http://neurology-healthcare.blogspot.com/2006/10/presentation-natural-history-and.html' title='Presentation, Natural History, and Management of Carotid Cavernous Aneurysms.'/><author><name>my-healthcare</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-27204255.post-115935136599446242</id><published>2006-10-01T02:55:00.000-07:00</published><updated>2006-10-01T10:01:50.263-07:00</updated><title type='text'>Acute Ischemic Stroke Care and Outcome.</title><summary type='text'>Results from many clinical trials have been used to develop guidelines for acute stroke care and for stroke prevention. Despite these recommendations, marked regional differences remain in quality of stroke care, which may impact recovery and outcome after stroke. Previous studies have shown that case fatality is high in Poland compared with other European countries. In 1997, the Ministry of </summary><link rel='replies' type='application/atom+xml' href='http://neurology-healthcare.blogspot.com/feeds/115935136599446242/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=27204255&amp;postID=115935136599446242' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/115935136599446242'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/115935136599446242'/><link rel='alternate' type='text/html' href='http://neurology-healthcare.blogspot.com/2006/10/acute-ischemic-stroke-care-and-outcome.html' title='Acute Ischemic Stroke Care and Outcome.'/><author><name>my-healthcare</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-27204255.post-115935066581610348</id><published>2006-09-26T02:45:00.000-07:00</published><updated>2006-09-27T02:51:05.830-07:00</updated><title type='text'>Use of serum prolactin in diagnosing epileptic seizures.</title><summary type='text'>Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.A recent AAN Practice Parameter concluded that postictal prolactin (PRL) elevation is useful in differentiating generalized tonic-clonic and complex partial seizures from psychogenic nonepileptic seizure. This observation was previously suggested by Trimble. An interesting finding is that serum </summary><link rel='replies' type='application/atom+xml' href='http://neurology-healthcare.blogspot.com/feeds/115935066581610348/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=27204255&amp;postID=115935066581610348' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/115935066581610348'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/115935066581610348'/><link rel='alternate' type='text/html' href='http://neurology-healthcare.blogspot.com/2006/09/use-of-serum-prolactin-in-diagnosing.html' title='Use of serum prolactin in diagnosing epileptic seizures.'/><author><name>my-healthcare</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-27204255.post-115908585122963704</id><published>2006-09-22T15:07:00.000-07:00</published><updated>2006-09-24T01:17:31.986-07:00</updated><title type='text'>Neurologists in war: Personal perspective</title><summary type='text'>U.S. neurologists in IraqIt didn’t seem real until that nighttime helicopter ride. Lights out, machine guns up, and skimming a mere 50 feet over rooftops at over 150 miles per hour. We were en route to the Combat Support Hospital (CSH) located in Baghdad at the frontline of the Global War on Terror. That is when we came to the full realization that we were joining a long line of neurologists </summary><link rel='replies' type='application/atom+xml' href='http://neurology-healthcare.blogspot.com/feeds/115908585122963704/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=27204255&amp;postID=115908585122963704' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/115908585122963704'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/115908585122963704'/><link rel='alternate' type='text/html' href='http://neurology-healthcare.blogspot.com/2006/09/neurologists-in-war-personal.html' title='Neurologists in war: Personal perspective'/><author><name>my-healthcare</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-27204255.post-115470181803117621</id><published>2006-09-13T07:26:00.000-07:00</published><updated>2006-09-13T04:39:06.670-07:00</updated><title type='text'>Neurologist-induced sexual dysfunction: Enzyme-inducing antiepileptic drugs.</title><summary type='text'>Sex remains an awkward area for most patients and physicians to discuss, not routinely covered during clinical visits despite its importance to the individual and the frequency of disorders. Central and peripheral nervous system diseases often compromise libido and sexual function, either directly or by psychological reactions. Further, medications prescribed by neurologists and other physicians </summary><link rel='replies' type='application/atom+xml' href='http://neurology-healthcare.blogspot.com/feeds/115470181803117621/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=27204255&amp;postID=115470181803117621' title='5 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/115470181803117621'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/115470181803117621'/><link rel='alternate' type='text/html' href='http://neurology-healthcare.blogspot.com/2006/09/neurologist-induced-sexual-dysfunction.html' title='Neurologist-induced sexual dysfunction: Enzyme-inducing antiepileptic drugs.'/><author><name>my-healthcare</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>5</thr:total></entry><entry><id>tag:blogger.com,1999:blog-27204255.post-115470157661355152</id><published>2006-09-07T07:15:00.000-07:00</published><updated>2006-09-08T01:39:26.510-07:00</updated><title type='text'>Driving after a stroke.</title><summary type='text'>Crashes involving elderly drivers hitting pedestrians are increasing at an alarming rate. With the graying of America, the impact of driving impairment is being reported more commonly. In the year 2000 (according to US Census data), people over the age of 65 equaled 13% of the United States population yet were involved in 18% of all traffic fatalities. Many medical conditions may lead to problems</summary><link rel='replies' type='application/atom+xml' href='http://neurology-healthcare.blogspot.com/feeds/115470157661355152/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=27204255&amp;postID=115470157661355152' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/115470157661355152'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/115470157661355152'/><link rel='alternate' type='text/html' href='http://neurology-healthcare.blogspot.com/2006/09/driving-after-stroke.html' title='Driving after a stroke.'/><author><name>my-healthcare</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-27204255.post-115470091284274038</id><published>2006-08-27T07:08:00.000-07:00</published><updated>2006-08-28T23:03:42.616-07:00</updated><title type='text'>Fruit and vegetable consumption and risk of stroke.</title><summary type='text'>Epidemiologic studies of the association between fruit and vegetable intake and coronary heart disease (CHD) have shown that greater fruit and vegetable intake is associated with decreased CHD. A recent pooled analysis of cohort studies noted that consumption of fiber from cereals and fruit is associated with a decreased risk of CHD. These observations support the recommendation to eat fruit and </summary><link rel='replies' type='application/atom+xml' href='http://neurology-healthcare.blogspot.com/feeds/115470091284274038/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=27204255&amp;postID=115470091284274038' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/115470091284274038'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/115470091284274038'/><link rel='alternate' type='text/html' href='http://neurology-healthcare.blogspot.com/2006/08/fruit-and-vegetable-consumption-and.html' title='Fruit and vegetable consumption and risk of stroke.'/><author><name>my-healthcare</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-27204255.post-115470045084589127</id><published>2006-08-24T07:03:00.000-07:00</published><updated>2006-08-23T20:30:03.136-07:00</updated><title type='text'>Love, death, and the brainstem.</title><summary type='text'>There is nothing particularly compelling about a 78-year-old man with a gait disturbance and occasional loss of bladder control. The question I needed to address was: Did he also have cognitive decline?Our department has devoted considerable attention to “the special clinical problem of symptomatic hydrocephalus with normal CSF pressure.” We developed a cognitive and gait assessment battery to </summary><link rel='replies' type='application/atom+xml' href='http://neurology-healthcare.blogspot.com/feeds/115470045084589127/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=27204255&amp;postID=115470045084589127' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/115470045084589127'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/115470045084589127'/><link rel='alternate' type='text/html' href='http://neurology-healthcare.blogspot.com/2006/08/love-death-and-brainstem.html' title='Love, death, and the brainstem.'/><author><name>my-healthcare</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-27204255.post-115469437000370837</id><published>2006-08-21T11:15:00.000-07:00</published><updated>2006-08-22T01:28:52.536-07:00</updated><title type='text'>Not all dementia is Alzheimer: Dementia with Lewy bodies.</title><summary type='text'>Dementia with Lewy bodies (DLB) can be a tricky disease to understand. In simple terms, DLB is a combination of dementia and Parkinson disease (PD). Dementia refers to a problem with normal daily activities due to problems thinking. The most common problems in dementia are short-term memory loss, lack of drive, and slowed thinking. PD typically includes a tremor (shaking) that is present at rest,</summary><link rel='replies' type='application/atom+xml' href='http://neurology-healthcare.blogspot.com/feeds/115469437000370837/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=27204255&amp;postID=115469437000370837' title='1 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/115469437000370837'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/115469437000370837'/><link rel='alternate' type='text/html' href='http://neurology-healthcare.blogspot.com/2006/08/not-all-dementia-is-alzheimer-dementia.html' title='Not all dementia is Alzheimer: Dementia with Lewy bodies.'/><author><name>my-healthcare</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>1</thr:total></entry><entry><id>tag:blogger.com,1999:blog-27204255.post-115469373207125826</id><published>2006-08-18T13:12:00.000-07:00</published><updated>2006-08-17T23:11:06.320-07:00</updated><title type='text'>The away neurology rotation: Is the grass greener on the other side?.</title><summary type='text'>Advantages of an away rotation.A common reason to consider an away rotation is the availability of training or expertise at an outside institution that cannot be afforded elsewhere. Often this rotation allows the individual to gain a fresh perspective for approaching particular medical problems. Although medicine consists of certain undeniable facts, it still is an art open to varying </summary><link rel='replies' type='application/atom+xml' href='http://neurology-healthcare.blogspot.com/feeds/115469373207125826/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=27204255&amp;postID=115469373207125826' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/115469373207125826'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/115469373207125826'/><link rel='alternate' type='text/html' href='http://neurology-healthcare.blogspot.com/2006/08/away-neurology-rotation-is-grass.html' title='The away neurology rotation: Is the grass greener on the other side?.'/><author><name>my-healthcare</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-27204255.post-115469356533276307</id><published>2006-08-15T05:10:00.000-07:00</published><updated>2006-08-14T20:59:22.720-07:00</updated><title type='text'>Initial pharmacotherapy in a population of veterans with Parkinson disease.</title><summary type='text'>Since the advent of the first dopamine agonist (DA), controversy has existed regarding the choice of medication for the initial therapy of PD. While levodopa (LD) remains the most potent medication to relieve the cardinal symptoms of PD, the disabling complications, dyskinesias and motor fluctuations, may be prevented by initial therapy with a non-LD medication.Recent clinical trials </summary><link rel='replies' type='application/atom+xml' href='http://neurology-healthcare.blogspot.com/feeds/115469356533276307/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=27204255&amp;postID=115469356533276307' title='3 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/115469356533276307'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/115469356533276307'/><link rel='alternate' type='text/html' href='http://neurology-healthcare.blogspot.com/2006/08/initial-pharmacotherapy-in-population.html' title='Initial pharmacotherapy in a population of veterans with Parkinson disease.'/><author><name>my-healthcare</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>3</thr:total></entry><entry><id>tag:blogger.com,1999:blog-27204255.post-115469330088764534</id><published>2006-08-12T08:53:00.000-07:00</published><updated>2006-08-12T00:08:23.853-07:00</updated><title type='text'>What’s the use?.</title><summary type='text'>I am beginning to take myself seriously. This is dangerous when it happens, and it is to be discouraged. It leads one’s thinking on unexpected paths, usually deeper into the forest with nary a breadcrumb to be seen. I was contemplating the Humanities section and wondering whether it had a Greater Purpose. After some reflection (no pun intended), I concluded that it did, but I will come to that </summary><link rel='replies' type='application/atom+xml' href='http://neurology-healthcare.blogspot.com/feeds/115469330088764534/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=27204255&amp;postID=115469330088764534' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/115469330088764534'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/115469330088764534'/><link rel='alternate' type='text/html' href='http://neurology-healthcare.blogspot.com/2006/08/whats-use.html' title='What’s the use?.'/><author><name>my-healthcare</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-27204255.post-114940018368240423</id><published>2006-08-09T08:33:00.000-07:00</published><updated>2006-08-08T20:53:15.610-07:00</updated><title type='text'>Community walking activity in neurological disorders with leg weakness.</title><summary type='text'>TitleCommunity walking activity in neurological disorders with leg weakness.SourceJournal of Neurology, Neurosurgery &amp; Psychiatry. 77(3):359-62, 2006 Mar.BACKGROUND:The aims of this study were to determine walking mobility in the community in individuals with lower limb weakness and to establish the extent to which some clinic based measures predict such activity. METHODS:Five groups (n = 12-18) </summary><link rel='replies' type='application/atom+xml' href='http://neurology-healthcare.blogspot.com/feeds/114940018368240423/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=27204255&amp;postID=114940018368240423' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/114940018368240423'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/114940018368240423'/><link rel='alternate' type='text/html' href='http://neurology-healthcare.blogspot.com/2006/08/community-walking-activity-in.html' title='Community walking activity in neurological disorders with leg weakness.'/><author><name>my-healthcare</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-27204255.post-114939920474938938</id><published>2006-08-06T07:22:00.000-07:00</published><updated>2006-08-05T06:48:18.146-07:00</updated><title type='text'>Headache and migraine in primary care: consultation, prescription, and referral rates in a large population.</title><summary type='text'>TitleHeadache and migraine in primary care: consultation, prescription, and referral rates in a large population.SourceJournal of Neurology, Neurosurgery &amp; Psychiatry. 77(3):385-7, 2006 Mar.BACKGROUND/AIMS:Headache is the most common new neurological symptom seen by general practitioners and neurologists. This study describes headache consultation, prescription, and referral rates in a large </summary><link rel='replies' type='application/atom+xml' href='http://neurology-healthcare.blogspot.com/feeds/114939920474938938/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=27204255&amp;postID=114939920474938938' title='27 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/114939920474938938'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/114939920474938938'/><link rel='alternate' type='text/html' href='http://neurology-healthcare.blogspot.com/2006/08/headache-and-migraine-in-primary-care.html' title='Headache and migraine in primary care: consultation, prescription, and referral rates in a large population.'/><author><name>my-healthcare</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>27</thr:total></entry><entry><id>tag:blogger.com,1999:blog-27204255.post-114939801417948509</id><published>2006-08-03T07:01:00.000-07:00</published><updated>2006-08-01T02:09:06.443-07:00</updated><title type='text'>Long-term outcome after temporal lobe surgery--prediction of late worsening of seizure control.</title><summary type='text'>TitleLong-term outcome after temporal lobe surgery--prediction of late worsening of seizure control.SourceSeizure. 15(1):49-55, 2006 Jan.We analyzed possible predictors of late worsening of seizure control in 94 adult patients who had anterior temporal lobectomy (ATL) from the Epilepsy Center of the National Institute of Psychiatry and Neurology, Budapest between 1985 and 2001. We evaluated data </summary><link rel='replies' type='application/atom+xml' href='http://neurology-healthcare.blogspot.com/feeds/114939801417948509/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=27204255&amp;postID=114939801417948509' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/114939801417948509'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/114939801417948509'/><link rel='alternate' type='text/html' href='http://neurology-healthcare.blogspot.com/2006/08/long-term-outcome-after-temporal-lobe.html' title='Long-term outcome after temporal lobe surgery--prediction of late worsening of seizure control.'/><author><name>my-healthcare</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-27204255.post-114939715440307984</id><published>2006-07-31T07:58:00.000-07:00</published><updated>2006-07-30T22:31:10.660-07:00</updated><title type='text'>Congenital muscular torticollis.</title><summary type='text'>TitleCongenital muscular torticollis: evaluation and classification.SourcePediatric Neurology. 34(1):41-4, 2006 Jan.In this investigation of congenital muscular torticollis, 311 infants treated consecutively for congenital torticollis over an 8-year period (1995-2003) at the Pediatric Neurology Clinic of Istanbul Medical Faculty, Istanbul University, Turkey were reviewed retrospectively. The </summary><link rel='replies' type='application/atom+xml' href='http://neurology-healthcare.blogspot.com/feeds/114939715440307984/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=27204255&amp;postID=114939715440307984' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/114939715440307984'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/114939715440307984'/><link rel='alternate' type='text/html' href='http://neurology-healthcare.blogspot.com/2006/07/congenital-muscular-torticollis.html' title='Congenital muscular torticollis.'/><author><name>my-healthcare</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-27204255.post-114939659369778799</id><published>2006-07-27T21:20:00.000-07:00</published><updated>2006-07-28T03:35:47.810-07:00</updated><title type='text'>Prevention of osteoporosis in glucocorticoid-treated neurology patients.</title><summary type='text'>TitlePrevention of osteoporosis in glucocorticoid-treated neurology patients.SourceClinical Neurology &amp; Neurosurgery. 108(2):157-62, 2006 Feb.OBJECTIVES:Iatrogenic, including corticosteroid-induced osteoporosis is preventable with administration of osteoprotective biphosphonates. The best medical practice is published in the National Guidelines: UK Osteoporosis Consensus Group (1998, update 2002)</summary><link rel='replies' type='application/atom+xml' href='http://neurology-healthcare.blogspot.com/feeds/114939659369778799/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=27204255&amp;postID=114939659369778799' title='1 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/114939659369778799'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/114939659369778799'/><link rel='alternate' type='text/html' href='http://neurology-healthcare.blogspot.com/2006/07/prevention-of-osteoporosis-in.html' title='Prevention of osteoporosis in glucocorticoid-treated neurology patients.'/><author><name>my-healthcare</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>1</thr:total></entry><entry><id>tag:blogger.com,1999:blog-27204255.post-114939481010559191</id><published>2006-07-24T21:02:00.000-07:00</published><updated>2006-07-25T01:07:40.913-07:00</updated><title type='text'>Fruit and vegetable consumption and risk of stroke.</title><summary type='text'>TitleFruit and vegetable consumption and risk of stroke: a meta-analysis of cohort studies.SourceNeurology. 65(8):1193-7, 2005 Oct 25.BACKGROUND:Fruit and vegetable consumption is associated with lower rates of coronary heart disease. Results from observational studies suggest a similar association with stroke. OBJECTIVE:To assess the evidence from prospective observational studies on fruit and </summary><link rel='replies' type='application/atom+xml' href='http://neurology-healthcare.blogspot.com/feeds/114939481010559191/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=27204255&amp;postID=114939481010559191' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/114939481010559191'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/114939481010559191'/><link rel='alternate' type='text/html' href='http://neurology-healthcare.blogspot.com/2006/07/fruit-and-vegetable-consumption-and.html' title='Fruit and vegetable consumption and risk of stroke.'/><author><name>my-healthcare</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-27204255.post-114939367229028862</id><published>2006-07-21T11:57:00.000-07:00</published><updated>2006-07-21T10:22:35.203-07:00</updated><title type='text'>Family members favor disclosing the diagnosis of Alzheimer's disease.</title><summary type='text'>TitleFamily members favor disclosing the diagnosis of Alzheimer's disease.SourceInternational Psychogeriatrics. 17(4):679-88, 2005 Dec.BACKGROUND:Past negative attitudes towards patients with Alzheimer's disease (AD) have changed in recent years. However, the disclosure of AD diagnosis to patients and family remains an unresolved issue. In this study, we surveyed the family members of </summary><link rel='replies' type='application/atom+xml' href='http://neurology-healthcare.blogspot.com/feeds/114939367229028862/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=27204255&amp;postID=114939367229028862' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/114939367229028862'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/114939367229028862'/><link rel='alternate' type='text/html' href='http://neurology-healthcare.blogspot.com/2006/07/family-members-favor-disclosing_21.html' title='Family members favor disclosing the diagnosis of Alzheimer&apos;s disease.'/><author><name>my-healthcare</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-27204255.post-114939345091815159</id><published>2006-07-18T08:50:00.000-07:00</published><updated>2006-07-18T00:09:35.440-07:00</updated><title type='text'>Diagnosis and management of dementia with Lewy bodies.</title><summary type='text'>TitleDiagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium.SourceNeurology. 65(12):1863-72, 2005 Dec 27.The dementia with Lewy bodies (DLB) Consortium has revised criteria for the clinical and pathologic diagnosis of DLB incorporating new information about the core clinical features and suggesting improved methods to assess them. REM sleep behavior disorder, </summary><link rel='replies' type='application/atom+xml' href='http://neurology-healthcare.blogspot.com/feeds/114939345091815159/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=27204255&amp;postID=114939345091815159' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/114939345091815159'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/114939345091815159'/><link rel='alternate' type='text/html' href='http://neurology-healthcare.blogspot.com/2006/07/diagnosis-and-management-of-dementia.html' title='Diagnosis and management of dementia with Lewy bodies.'/><author><name>my-healthcare</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-27204255.post-114939298768703026</id><published>2006-07-15T15:53:00.000-07:00</published><updated>2006-07-16T20:23:30.460-07:00</updated><title type='text'>The clinical importance of neutralizing antibodies in relapsing-remitting multiple sclerosis.</title><summary type='text'>TitleThe clinical importance of neutralizing antibodies in relapsing-remitting multiple sclerosis. SourceCurrent Medical Research &amp; Opinion. 22(2):223-39, 2006 Feb.BACKGROUND:Neutralizing antibodies (NAbs) develop in patients receiving interferon beta (IFN-beta) for multiple sclerosis (MS). Debate continues concerning the relevance of NAb development on treatment efficacy. OBJECTIVE:To determine </summary><link rel='replies' type='application/atom+xml' href='http://neurology-healthcare.blogspot.com/feeds/114939298768703026/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=27204255&amp;postID=114939298768703026' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/114939298768703026'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/114939298768703026'/><link rel='alternate' type='text/html' href='http://neurology-healthcare.blogspot.com/2006/07/clinical-importance-of-neutralizing.html' title='The clinical importance of neutralizing antibodies in relapsing-remitting multiple sclerosis.'/><author><name>my-healthcare</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-27204255.post-114939261931040241</id><published>2006-07-12T06:39:00.000-07:00</published><updated>2006-07-12T19:39:49.893-07:00</updated><title type='text'>Carbamazepine extended-release capsules: a new treatment option for bipolar I disorder.</title><summary type='text'>TitleCarbamazepine extended-release capsules: a new treatment option for bipolar I disorder. SourceExpert Review of Neurotherapeutics. 5(5):587-95, 2005 Sep.Carbamazepine has a long history in psychiatry and neurology. More recently, carbamazepine extended-release capsules have been approved by the US Food and Drug Administration for the treatment of manic and mixed episodes associated with </summary><link rel='replies' type='application/atom+xml' href='http://neurology-healthcare.blogspot.com/feeds/114939261931040241/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=27204255&amp;postID=114939261931040241' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/114939261931040241'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/114939261931040241'/><link rel='alternate' type='text/html' href='http://neurology-healthcare.blogspot.com/2006/07/carbamazepine-extended-release.html' title='Carbamazepine extended-release capsules: a new treatment option for bipolar I disorder.'/><author><name>my-healthcare</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-27204255.post-114939235356007260</id><published>2006-07-09T08:36:00.000-07:00</published><updated>2006-07-10T01:51:01.313-07:00</updated><title type='text'>Hallucinations in Parkinson disease in the prelevodopa era.</title><summary type='text'>TitleHallucinations in Parkinson disease in the prelevodopa era.SourceNeurology. 66(1):93-8, 2006 Jan 10.Whether chronic hallucinations belong to the natural history of untreated Parkinson disease (PD) remains undetermined. For early authors such as Gowers or Charcot and his followers, hallucinations that occurred in the course of PD either accompanied the final phase of the disease or reflected </summary><link rel='replies' type='application/atom+xml' href='http://neurology-healthcare.blogspot.com/feeds/114939235356007260/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=27204255&amp;postID=114939235356007260' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/114939235356007260'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/114939235356007260'/><link rel='alternate' type='text/html' href='http://neurology-healthcare.blogspot.com/2006/07/hallucinations-in-parkinson-disease-in.html' title='Hallucinations in Parkinson disease in the prelevodopa era.'/><author><name>my-healthcare</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-27204255.post-114935245568589254</id><published>2006-07-06T09:32:00.000-07:00</published><updated>2006-07-07T03:48:22.746-07:00</updated><title type='text'>Toward a multimodal neuroprotective treatment of stroke.</title><summary type='text'>TitleToward a multimodal neuroprotective treatment of stroke. SourceStroke. 37(4):1129-36, 2006 Apr.BACKGROUND AND PURPOSE:Stroke remains a common medical problem with importance attributable to the demographic changes in industrialized societies. SUMMARY OF REVIEW:After years of setbacks, acute stroke therapy has finally emerged, including thrombolysis with tissue plasminogen activator (t-PA). </summary><link rel='replies' type='application/atom+xml' href='http://neurology-healthcare.blogspot.com/feeds/114935245568589254/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=27204255&amp;postID=114935245568589254' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/114935245568589254'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/114935245568589254'/><link rel='alternate' type='text/html' href='http://neurology-healthcare.blogspot.com/2006/07/toward-multimodal-neuroprotective.html' title='Toward a multimodal neuroprotective treatment of stroke.'/><author><name>my-healthcare</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-27204255.post-114939726284415054</id><published>2006-07-03T06:59:00.000-07:00</published><updated>2006-07-02T08:29:10.606-07:00</updated><title type='text'>Characterization of symptoms of sleep disorders in children with headache.</title><summary type='text'>TitleCharacterization of symptoms of sleep disorders in children with headache.SourcePediatric Neurology. 34(1):7-12, 2006 Jan.To investigate the prevalence of sleep disorders and their symptoms in children with headaches, 64 patients in the outpatient clinics of the University of Chicago Department of Pediatric Neurology were interviewed. Investigated disorders included excessive daytime </summary><link rel='replies' type='application/atom+xml' href='http://neurology-healthcare.blogspot.com/feeds/114939726284415054/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=27204255&amp;postID=114939726284415054' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/114939726284415054'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/114939726284415054'/><link rel='alternate' type='text/html' href='http://neurology-healthcare.blogspot.com/2006/07/characterization-of-symptoms-of-sleep.html' title='Characterization of symptoms of sleep disorders in children with headache.'/><author><name>my-healthcare</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-27204255.post-114935150963356064</id><published>2006-06-30T20:14:00.000-07:00</published><updated>2006-06-30T01:57:09.343-07:00</updated><title type='text'>Triplopia.</title><summary type='text'>TitleTriplopia: thirteen patients from a neurology inpatient service.SourceArchives of Neurology. 63(3):388-9, 2006 Mar.BACKGROUND:Seeing triple is a rare complaint, so anatomically unlikely that it is often considered a diagnostic symptom of hysteria. OBJECTIVE:To evaluate the complaint of triple vision among a large group of neurological inpatients. DESIGN: Personal case series during a 34-year</summary><link rel='replies' type='application/atom+xml' href='http://neurology-healthcare.blogspot.com/feeds/114935150963356064/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=27204255&amp;postID=114935150963356064' title='6 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/114935150963356064'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/114935150963356064'/><link rel='alternate' type='text/html' href='http://neurology-healthcare.blogspot.com/2006/06/triplopia.html' title='Triplopia.'/><author><name>my-healthcare</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>6</thr:total></entry><entry><id>tag:blogger.com,1999:blog-27204255.post-114935127296995128</id><published>2006-06-27T11:10:00.000-07:00</published><updated>2006-06-28T01:59:11.370-07:00</updated><title type='text'>Metabolic risk factor profile associated with use of second generation antipsychotics.</title><summary type='text'>Title Metabolic risk factor profile associated with use of second generation antipsychotics: a cross sectional study in a Community Mental Health Centre.Source BMC Psychiatry. 6:11, 2006.BACKGROUND:Second generation antipsychotics (SGA) have demonstrated several advantages over first generation antipsychotics (FGA) in terms of positive, negative, cognitive, and affective symptoms and a lower </summary><link rel='replies' type='application/atom+xml' href='http://neurology-healthcare.blogspot.com/feeds/114935127296995128/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=27204255&amp;postID=114935127296995128' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/114935127296995128'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/114935127296995128'/><link rel='alternate' type='text/html' href='http://neurology-healthcare.blogspot.com/2006/06/metabolic-risk-factor-profile.html' title='Metabolic risk factor profile associated with use of second generation antipsychotics.'/><author><name>my-healthcare</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-27204255.post-114935099636955086</id><published>2006-06-24T13:48:00.000-07:00</published><updated>2006-06-28T01:57:25.346-07:00</updated><title type='text'>Left thoracoscopic thymectomy in children.</title><summary type='text'>TitleLeft thoracoscopic thymectomy in children. SourceSurgical Endoscopy. 19(1):140-2, 2005 Jan.BACKGROUND:In the management of autoimmune myasthenia, thymectomy is recognized as effective surgical therapy. The necessity of complete radical thymectomy to achieve maximal improvement has been emphasized. Video-assisted thoracoscopic surgery has been successfully used for thymectomy in adults, and </summary><link rel='replies' type='application/atom+xml' href='http://neurology-healthcare.blogspot.com/feeds/114935099636955086/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=27204255&amp;postID=114935099636955086' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/114935099636955086'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/114935099636955086'/><link rel='alternate' type='text/html' href='http://neurology-healthcare.blogspot.com/2006/06/left-thoracoscopic-thymectomy-in.html' title='Left thoracoscopic thymectomy in children.'/><author><name>my-healthcare</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-27204255.post-114934966220473872</id><published>2006-06-21T20:38:00.000-07:00</published><updated>2006-06-21T20:25:02.506-07:00</updated><title type='text'>Seizure recurrence and risk factors after antiepilepsy drug withdrawal in children with brain tumors.</title><summary type='text'>TitleSeizure recurrence and risk factors after antiepilepsy drug withdrawal in children with brain tumors.SourceEpilepsia. 47(2):375-9, 2006 Feb.PURPOSE:To study seizure outcome after antiepilepsy drug (AED) withdrawal in brain tumor patients and to analyze risk factors for seizure recurrence. METHODS:Brain tumor patients with seizures and at least one attempt at AED discontinuation were </summary><link rel='replies' type='application/atom+xml' href='http://neurology-healthcare.blogspot.com/feeds/114934966220473872/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=27204255&amp;postID=114934966220473872' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/114934966220473872'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/114934966220473872'/><link rel='alternate' type='text/html' href='http://neurology-healthcare.blogspot.com/2006/06/seizure-recurrence-and-risk-factors.html' title='Seizure recurrence and risk factors after antiepilepsy drug withdrawal in children with brain tumors.'/><author><name>my-healthcare</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-27204255.post-114934903467316707</id><published>2006-06-18T07:57:00.000-07:00</published><updated>2006-06-17T21:39:07.366-07:00</updated><title type='text'>Diagnosis and prognosis of new onset Parkinson disease.</title><summary type='text'>TitlePractice Parameter: diagnosis and prognosis of new onset Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.SourceNeurology. 66(7):968-75, 2006 Apr 11.OBJECTIVE:To define key issues in the diagnosis of Parkinson disease (PD), to define features influencing progression, and to make evidence-based recommendations. Two</summary><link rel='replies' type='application/atom+xml' href='http://neurology-healthcare.blogspot.com/feeds/114934903467316707/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=27204255&amp;postID=114934903467316707' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/114934903467316707'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/114934903467316707'/><link rel='alternate' type='text/html' href='http://neurology-healthcare.blogspot.com/2006/06/diagnosis-and-prognosis-of-new-onset.html' title='Diagnosis and prognosis of new onset Parkinson disease.'/><author><name>my-healthcare</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-27204255.post-114934662879086758</id><published>2006-06-15T07:42:00.000-07:00</published><updated>2006-06-14T19:35:05.683-07:00</updated><title type='text'>Neuroprotective strategies and alternative therapies for Parkinson disease.</title><summary type='text'>TitlePractice Parameter: neuroprotective strategies and alternative therapies for Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.SourceNeurology. 66(7):976-82, 2006 Apr 11.OBJECTIVE:To define key issues in the management of Parkinson disease (PD) relating to neuroprotective strategies and alternative treatments, and </summary><link rel='replies' type='application/atom+xml' href='http://neurology-healthcare.blogspot.com/feeds/114934662879086758/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=27204255&amp;postID=114934662879086758' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/114934662879086758'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/114934662879086758'/><link rel='alternate' type='text/html' href='http://neurology-healthcare.blogspot.com/2006/06/neuroprotective-strategies-and.html' title='Neuroprotective strategies and alternative therapies for Parkinson disease.'/><author><name>my-healthcare</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-27204255.post-114933323115112989</id><published>2006-06-12T11:03:00.000-07:00</published><updated>2006-06-12T04:45:15.850-07:00</updated><title type='text'>Treatment of Parkinson disease with motor fluctuations and dyskinesia.</title><summary type='text'>TitlePractice Parameter: treatment of Parkinson disease with motor fluctuations and dyskinesia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. SourceNeurology. 66(7):983-95, 2006 Apr 11.OBJECTIVE:To make evidence-based treatment recommendations for the medical and surgical treatment of patients with Parkinson disease (PD) with </summary><link rel='replies' type='application/atom+xml' href='http://neurology-healthcare.blogspot.com/feeds/114933323115112989/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=27204255&amp;postID=114933323115112989' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/114933323115112989'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/114933323115112989'/><link rel='alternate' type='text/html' href='http://neurology-healthcare.blogspot.com/2006/06/treatment-of-parkinson-disease-with.html' title='Treatment of Parkinson disease with motor fluctuations and dyskinesia.'/><author><name>my-healthcare</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-27204255.post-114933259890890066</id><published>2006-06-08T14:58:00.000-07:00</published><updated>2006-06-09T07:39:05.796-07:00</updated><title type='text'>Evaluation and treatment of depression, psychosis, and dementia in Parkinson disease.</title><summary type='text'>TitlePractice Parameter: evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.SourceNeurology. 66(7):996-1002, 2006 Apr 11.OBJECTIVE:To make evidence-based treatment recommendations for patients with Parkinson disease (PD) with dementia, depression, and </summary><link rel='replies' type='application/atom+xml' href='http://neurology-healthcare.blogspot.com/feeds/114933259890890066/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=27204255&amp;postID=114933259890890066' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/114933259890890066'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/114933259890890066'/><link rel='alternate' type='text/html' href='http://neurology-healthcare.blogspot.com/2006/06/evaluation-and-treatment-of-depression.html' title='Evaluation and treatment of depression, psychosis, and dementia in Parkinson disease.'/><author><name>my-healthcare</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-27204255.post-114933207208061968</id><published>2006-06-05T09:50:00.000-07:00</published><updated>2006-06-09T07:37:23.746-07:00</updated><title type='text'>Advances in treatment of pediatric brain tumors.</title><summary type='text'>TitleAdvances in treatment of pediatric brain tumors. SourceNeuroRx. 3(2):276-91, 2006 Apr.The long-term survival of children with brain tumor has improved considerably in the last three decades, owing to advances in neuroimaging, neurosurgical, and radiation therapy modalities, coupled with the application of conventional chemotherapy. MRI, MR spectroscopy and diffusion-weighted MRI have </summary><link rel='replies' type='application/atom+xml' href='http://neurology-healthcare.blogspot.com/feeds/114933207208061968/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=27204255&amp;postID=114933207208061968' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/114933207208061968'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/114933207208061968'/><link rel='alternate' type='text/html' href='http://neurology-healthcare.blogspot.com/2006/06/advances-in-treatment-of-pediatric.html' title='Advances in treatment of pediatric brain tumors.'/><author><name>my-healthcare</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-27204255.post-114933184889096548</id><published>2006-06-02T23:50:00.000-07:00</published><updated>2006-06-03T03:50:48.900-07:00</updated><title type='text'>Spontaneous motor activity three months after birth in comparison with clinical and ultrasound studies.</title><summary type='text'>TitleSpontaneous motor activity three months after birth in comparison with clinical and ultrasound studies.SourceFolia Medica (Plovdiv). 47(2):18-23, 2005.The introduction of the general movement assessment into pediatric practice as a prognostic method has prompted the necessity of further, more extended study of spontaneous motor activity. Possible correlations of this method with the </summary><link rel='replies' type='application/atom+xml' href='http://neurology-healthcare.blogspot.com/feeds/114933184889096548/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=27204255&amp;postID=114933184889096548' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/114933184889096548'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/114933184889096548'/><link rel='alternate' type='text/html' href='http://neurology-healthcare.blogspot.com/2006/06/spontaneous-motor-activity-three.html' title='Spontaneous motor activity three months after birth in comparison with clinical and ultrasound studies.'/><author><name>my-healthcare</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-27204255.post-114892392086810621</id><published>2006-05-29T10:29:00.000-07:00</published><updated>2006-05-29T10:32:00.870-07:00</updated><title type='text'>Spinal cord injury secondary to cervical hyperflexion with exercise.</title><summary type='text'>TitleSpinal cord injury in a 14-year-old male secondary to cervical hyperflexion with exercise.SourceSpinal Cord. 44(3):192-5, 2006 Mar.OBJECTIVES:To present an interesting case of a 14-year-old male with acute paresis of upper extremities and progressive difficulty with lower extremities. The patient is a competitive wrestler and was performing his daily abdominal workout 'sit-ups' with hands </summary><link rel='replies' type='application/atom+xml' href='http://neurology-healthcare.blogspot.com/feeds/114892392086810621/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=27204255&amp;postID=114892392086810621' title='1 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/114892392086810621'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/114892392086810621'/><link rel='alternate' type='text/html' href='http://neurology-healthcare.blogspot.com/2006/05/spinal-cord-injury-secondary-to.html' title='Spinal cord injury secondary to cervical hyperflexion with exercise.'/><author><name>my-healthcare</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>1</thr:total></entry><entry><id>tag:blogger.com,1999:blog-27204255.post-114892376602690088</id><published>2006-05-26T08:26:00.000-07:00</published><updated>2006-05-29T10:29:26.030-07:00</updated><title type='text'>Rapid detection of major depression in epilepsy.</title><summary type='text'>TitleRapid detection of major depression in epilepsy: a multicentre study.SourceLancet Neurology. 5(5):399-405, 2006 May.BACKGROUND:Depression is a common comorbid disorder in epilepsy but is not routinely assessed in neurology clinics. We aimed to create a rapid yet accurate screening instrument for major depression in people with epilepsy. METHODS:We developed a set of 46 items to identify </summary><link rel='replies' type='application/atom+xml' href='http://neurology-healthcare.blogspot.com/feeds/114892376602690088/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=27204255&amp;postID=114892376602690088' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/114892376602690088'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/114892376602690088'/><link rel='alternate' type='text/html' href='http://neurology-healthcare.blogspot.com/2006/05/rapid-detection-of-major-depression-in.html' title='Rapid detection of major depression in epilepsy.'/><author><name>my-healthcare</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-27204255.post-114892353059105464</id><published>2006-05-23T11:28:00.000-07:00</published><updated>2006-05-29T10:25:30.593-07:00</updated><title type='text'>Physical activity in children/teens with epilepsy compared with that in their siblings without epilepsy.</title><summary type='text'>TitlePhysical activity in children/teens with epilepsy compared with that in their siblings without epilepsy.SourceEpilepsia. 47(3):631-9, 2006 Mar.PURPOSE:To determine (a) whether children and teens with epilepsy participate in less physical activity and have higher body mass index (BMI) percentiles for age than do their siblings without epilepsy; and (b) what epilepsy-specific factors limit </summary><link rel='replies' type='application/atom+xml' href='http://neurology-healthcare.blogspot.com/feeds/114892353059105464/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=27204255&amp;postID=114892353059105464' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/114892353059105464'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/114892353059105464'/><link rel='alternate' type='text/html' href='http://neurology-healthcare.blogspot.com/2006/05/physical-activity-in-childrenteens.html' title='Physical activity in children/teens with epilepsy compared with that in their siblings without epilepsy.'/><author><name>my-healthcare</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-27204255.post-114892306988192624</id><published>2006-05-20T07:14:00.000-07:00</published><updated>2006-05-29T10:17:49.896-07:00</updated><title type='text'>National patterns of dementia treatment among elderly ambulatory patients.</title><summary type='text'>TitleNational patterns of dementia treatment among elderly ambulatory patients.SourceJournal of the National Medical Association. 98(3):430-5, 2006 Mar.PURPOSES:To assess patterns of dementia/Alzheimer's disease (AD) management and to investigate predictive factors of cholinesterase inhibitor prescriptions.  METHODOLOGY:A cross-sectional study was conducted using a national survey among the </summary><link rel='replies' type='application/atom+xml' href='http://neurology-healthcare.blogspot.com/feeds/114892306988192624/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=27204255&amp;postID=114892306988192624' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/114892306988192624'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/114892306988192624'/><link rel='alternate' type='text/html' href='http://neurology-healthcare.blogspot.com/2006/05/national-patterns-of-dementia.html' title='National patterns of dementia treatment among elderly ambulatory patients.'/><author><name>my-healthcare</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-27204255.post-114892284169637313</id><published>2006-05-17T10:01:00.000-07:00</published><updated>2006-05-29T10:14:01.710-07:00</updated><title type='text'>Neurological abnormalities in young adults born preterm.</title><summary type='text'>TitleNeurological abnormalities in young adults born preterm.SourceJournal of Neurology, Neurosurgery &amp; Psychiatry. 77(4):495-9, 2006 Apr.OBJECTIVE:Individuals born before 33 weeks' gestation (very preterm, VPT) have an increased likelihood of neurological abnormality, impaired cognitive function, and reduced academic performance in childhood. It is currently not known whether neurological signs </summary><link rel='replies' type='application/atom+xml' href='http://neurology-healthcare.blogspot.com/feeds/114892284169637313/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=27204255&amp;postID=114892284169637313' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/114892284169637313'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/114892284169637313'/><link rel='alternate' type='text/html' href='http://neurology-healthcare.blogspot.com/2006/05/neurological-abnormalities-in-young.html' title='Neurological abnormalities in young adults born preterm.'/><author><name>my-healthcare</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-27204255.post-114767569712293344</id><published>2006-05-14T23:45:00.000-07:00</published><updated>2006-05-14T23:48:17.130-07:00</updated><title type='text'>Do people with Parkinson's disease change strategy during unplanned gait termination?</title><summary type='text'>TitleDo people with Parkinson's disease change strategy during unplanned gait termination?.SourceNeuroscience Letters. 397(3):240-4, 2006 Apr 24.In light of the movement control problems reported for patients with Parkinson's disease (PD), we examined the lower extremity control strategies used by these subjects to stop walking in planned and unplanned situations. We compared how patients with PD</summary><link rel='replies' type='application/atom+xml' href='http://neurology-healthcare.blogspot.com/feeds/114767569712293344/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=27204255&amp;postID=114767569712293344' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/114767569712293344'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/114767569712293344'/><link rel='alternate' type='text/html' href='http://neurology-healthcare.blogspot.com/2006/05/do-people-with-parkinsons-disease.html' title='Do people with Parkinson&apos;s disease change strategy during unplanned gait termination?'/><author><name>my-healthcare</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-27204255.post-114744957995654084</id><published>2006-05-12T08:21:00.000-07:00</published><updated>2006-05-12T08:59:41.856-07:00</updated><title type='text'>Configural processing in autism and its relationship to face processing.</title><summary type='text'>TitleConfigural processing in autism and its relationship to face processing.SourceNeuropsychologia. 44(1):110-29, 2006.Studies of the perceptual performance of individuals with autism have focused, to a large extent, on two domains of visual behavior, one associated with face processing and the other associated with global or holistic processing. Whether autistic individuals differ from </summary><link rel='replies' type='application/atom+xml' href='http://neurology-healthcare.blogspot.com/feeds/114744957995654084/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=27204255&amp;postID=114744957995654084' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/114744957995654084'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/114744957995654084'/><link rel='alternate' type='text/html' href='http://neurology-healthcare.blogspot.com/2006/05/configural-processing-in-autism-and.html' title='Configural processing in autism and its relationship to face processing.'/><author><name>my-healthcare</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-27204255.post-114737055054823054</id><published>2006-05-10T23:20:00.000-07:00</published><updated>2006-05-11T11:02:30.556-07:00</updated><title type='text'>Repeat intrathecal triamcinolone acetonide application for relapsing remitting multiple sclerosis.</title><summary type='text'>TitleRepeat intrathecal triamcinolone acetonide application reduces acute occurring painful dysesthesia in patients with relapsing remitting multiple sclerosis.SourceThescientificworldjournal. 6:460-5, 2006.Four patients with relapsing remitting multiple sclerosis (RRMS) who experienced a relapse with acute onset of painful sensations. Pain sensations disappeared in two of them and markedly </summary><link rel='replies' type='application/atom+xml' href='http://neurology-healthcare.blogspot.com/feeds/114737055054823054/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=27204255&amp;postID=114737055054823054' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/114737055054823054'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/114737055054823054'/><link rel='alternate' type='text/html' href='http://neurology-healthcare.blogspot.com/2006/05/repeat-intrathecal-triamcinolone.html' title='Repeat intrathecal triamcinolone acetonide application for relapsing remitting multiple sclerosis.'/><author><name>my-healthcare</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-27204255.post-114690173204465905</id><published>2006-05-06T10:42:00.000-07:00</published><updated>2006-05-06T00:48:52.046-07:00</updated><title type='text'>Topiramate for the treatment of epilepsy and other nervous system disorders.</title><summary type='text'>TitleTopiramate for the treatment of epilepsy and other nervous system disorders.SourceExpert Review of Neurotherapeutics. 6(1):19-31, 2006 Jan."Initially synthesized as an oral hypoglycemic agent, topiramate was approved for use as an anticonvulsant in 1996. Its broad spectrum efficacy in epilepsy, including as monotherapy and in children, is well established. Topiramate has also been used in </summary><link rel='replies' type='application/atom+xml' href='http://neurology-healthcare.blogspot.com/feeds/114690173204465905/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=27204255&amp;postID=114690173204465905' title='1 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/114690173204465905'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/114690173204465905'/><link rel='alternate' type='text/html' href='http://neurology-healthcare.blogspot.com/2006/05/topiramate-for-treatment-of-epilepsy.html' title='Topiramate for the treatment of epilepsy and other nervous system disorders.'/><author><name>my-healthcare</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>1</thr:total></entry><entry><id>tag:blogger.com,1999:blog-27204255.post-114690062330740047</id><published>2006-05-05T12:14:00.000-07:00</published><updated>2006-05-06T00:30:23.313-07:00</updated><title type='text'>thoracic outlet syndrome &amp; surgical treatment.</title><summary type='text'>The thoracic outlet syndrome is a polymorphic clinical entity, whose nature is essentially anatomic, caused by the chronic compression of the neurovascular structures that are originated in the chest or neck and course to the upper extremity. According to the most affected structure, they can be classified as neurologic, arterial or venous syndromes, that may cause discomfort, pain and disability</summary><link rel='replies' type='application/atom+xml' href='http://neurology-healthcare.blogspot.com/feeds/114690062330740047/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=27204255&amp;postID=114690062330740047' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/114690062330740047'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/114690062330740047'/><link rel='alternate' type='text/html' href='http://neurology-healthcare.blogspot.com/2006/05/thoracic-outlet-syndrome-surgical.html' title='thoracic outlet syndrome &amp; surgical treatment.'/><author><name>my-healthcare</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-27204255.post-114648865029411495</id><published>2006-05-01T19:40:00.000-07:00</published><updated>2006-05-01T06:04:11.850-07:00</updated><title type='text'>Allergy, histamine 1 receptor blockers, and the risk of multiple sclerosis.</title><summary type='text'>TitleAllergy, histamine 1 receptor blockers, and the risk of multiple sclerosis.SourceNeurology. 66(4):572-5, 2006 Feb 28.BACKGROUND:It is unclear whether allergic diseases are associated with multiple sclerosis (MS), but histamine 1 receptor blockers, used in the treatment of allergic conditions, decreased the severity of experimental autoimmune encephalomyelitis (an animal model of MS). </summary><link rel='replies' type='application/atom+xml' href='http://neurology-healthcare.blogspot.com/feeds/114648865029411495/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=27204255&amp;postID=114648865029411495' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/114648865029411495'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/114648865029411495'/><link rel='alternate' type='text/html' href='http://neurology-healthcare.blogspot.com/2006/05/allergy-histamine-1-receptor-blockers.html' title='Allergy, histamine 1 receptor blockers, and the risk of multiple sclerosis.'/><author><name>my-healthcare</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-27204255.post-114648698914415085</id><published>2006-04-28T05:21:00.000-07:00</published><updated>2006-05-01T05:38:39.433-07:00</updated><title type='text'>Lithium for the treatment of adolescents with bipolar depression.</title><summary type='text'> TitleOpen-label lithium for the treatment of adolescents with bipolar depression.SourceJournal of the American Academy of Child &amp; Adolescent Psychiatry. 45(3):289-97, 2006 Mar.AbstractOBJECTIVES:To investigate the effectiveness and tolerability of lithium for the treatment of acute depression in adolescents with bipolar disorder. We hypothesized that patients receiving open-label treatment with </summary><link rel='replies' type='application/atom+xml' href='http://neurology-healthcare.blogspot.com/feeds/114648698914415085/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=27204255&amp;postID=114648698914415085' title='1 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/114648698914415085'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/114648698914415085'/><link rel='alternate' type='text/html' href='http://neurology-healthcare.blogspot.com/2006/04/lithium-for-treatment-of-adolescents.html' title='Lithium for the treatment of adolescents with bipolar depression.'/><author><name>my-healthcare</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>1</thr:total></entry><entry><id>tag:blogger.com,1999:blog-27204255.post-114647786828998731</id><published>2006-04-25T12:43:00.000-07:00</published><updated>2006-05-01T05:20:22.106-07:00</updated><title type='text'>HIV-associated peripheral neuropathies.</title><summary type='text'>TitleHuman immunodeficiency virus-associated peripheral neuropathies.SourceMayo Clinic Proceedings. 81(2):213-9, 2006 Feb.The availability of potent antiretroviral drugs and their use in 3 or more combination regimens, highly active antiretroviral therapy (HAART), have led to a substantial decline in the morbidity and mortality associated with human immunodeficiency virus (HIV) infection. </summary><link rel='replies' type='application/atom+xml' href='http://neurology-healthcare.blogspot.com/feeds/114647786828998731/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=27204255&amp;postID=114647786828998731' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/114647786828998731'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/114647786828998731'/><link rel='alternate' type='text/html' href='http://neurology-healthcare.blogspot.com/2006/04/hiv-associated-peripheral-neuropathies.html' title='HIV-associated peripheral neuropathies.'/><author><name>my-healthcare</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-27204255.post-114647928845797210</id><published>2006-04-20T20:06:00.000-07:00</published><updated>2006-05-01T05:18:20.676-07:00</updated><title type='text'>Neurogenic thoracic outlet syndromes</title><summary type='text'>TitleNeurogenic thoracic outlet syndromes: a comparison of true and nonspecific syndromes after surgical treatment.SourceSurgical Neurology. 65(3):262-71; discussion 271-2, 2006 Mar.BACKGROUND:Neurogenic thoracic outlet syndrome (NTOS) is attributed to compression of the brachial plexus at the scalene hiatus. Patients with true NTOS (TNTOS) have typical clinical and electrophysiological changes </summary><link rel='replies' type='application/atom+xml' href='http://neurology-healthcare.blogspot.com/feeds/114647928845797210/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=27204255&amp;postID=114647928845797210' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/114647928845797210'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/114647928845797210'/><link rel='alternate' type='text/html' href='http://neurology-healthcare.blogspot.com/2006/04/neurogenic-thoracic-outlet-syndromes.html' title='Neurogenic thoracic outlet syndromes'/><author><name>my-healthcare</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-27204255.post-114648574124550805</id><published>2006-04-16T17:01:00.000-07:00</published><updated>2006-05-01T05:15:43.266-07:00</updated><title type='text'>Lamotrigine adjunct or monotherapy for the treatment of adolescents with bipolar depression.</title><summary type='text'>TitleAn open-label study of lamotrigine adjunct or monotherapy for the treatment of adolescents with bipolar depression.SourceJournal of the American Academy of Child &amp; Adolescent Psychiatry. 45(3):298-304, 2006 Mar.OBJECTIVE: The treatment of pediatric bipolar depression has not been well studied. The authors wished to prospectively study the efficacy of lamotrigine as adjunctive or monotherapy </summary><link rel='replies' type='application/atom+xml' href='http://neurology-healthcare.blogspot.com/feeds/114648574124550805/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=27204255&amp;postID=114648574124550805' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/114648574124550805'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/114648574124550805'/><link rel='alternate' type='text/html' href='http://neurology-healthcare.blogspot.com/2006/04/lamotrigine-adjunct-or-monotherapy-for.html' title='Lamotrigine adjunct or monotherapy for the treatment of adolescents with bipolar depression.'/><author><name>my-healthcare</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-27204255.post-114647643373027868</id><published>2006-04-12T14:24:00.000-07:00</published><updated>2006-05-01T05:19:06.970-07:00</updated><title type='text'>Cholinesterase inhibitors for Parkinson's disease dementia.</title><summary type='text'>TitleCholinesterase inhibitors for Parkinson's disease dementia.SourceCochrane Database of Systematic Reviews. (1):CD004747, 2006.BACKGROUND:The loss of cholinergic, dopaminergic and noradrenergic innervations seen in Parkinson's Disease Dementia (PDD) suggest a potential role for cholinesterase inhibitors. Concerns have been expressed about a theoretical worsening of Parkinson's disease related </summary><link rel='replies' type='application/atom+xml' href='http://neurology-healthcare.blogspot.com/feeds/114647643373027868/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=27204255&amp;postID=114647643373027868' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/114647643373027868'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/114647643373027868'/><link rel='alternate' type='text/html' href='http://neurology-healthcare.blogspot.com/2006/04/cholinesterase-inhibitors-for.html' title='Cholinesterase inhibitors for Parkinson&apos;s disease dementia.'/><author><name>my-healthcare</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-27204255.post-114645948784770670</id><published>2006-04-07T21:41:00.000-07:00</published><updated>2006-04-30T23:50:56.450-07:00</updated><title type='text'>Depression and suicide in adolescents with epilepsy.</title><summary type='text'>Depression and suicide in adolescents with epilepsy.    SourceNeurology. 66(6 Suppl 3):S5-12, 2006 Mar 28."Depression and other disorders are underdiagnosed and undertreated in young people with epilepsy. Signs of depression are often dismissed as "normal" reactions, even though depression is a life-threatening disease and a risk factor for suicide. A strong correlation between epilepsy and </summary><link rel='replies' type='application/atom+xml' href='http://neurology-healthcare.blogspot.com/feeds/114645948784770670/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=27204255&amp;postID=114645948784770670' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/114645948784770670'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/114645948784770670'/><link rel='alternate' type='text/html' href='http://neurology-healthcare.blogspot.com/2006/04/depression-and-suicide-in-adolescents.html' title='Depression and suicide in adolescents with epilepsy.'/><author><name>my-healthcare</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-27204255.post-114639974426814745</id><published>2006-04-05T17:06:00.000-07:00</published><updated>2006-04-30T05:22:24.306-07:00</updated><title type='text'></title><summary type='text'>Psychological interventions for multiple sclerosis.   SourceCochrane Database of Systematic Reviews. (1):CD004431, 2006.   BACKGROUND: The unpredictable, variable nature of Multiple Sclerosis (MS), and the possibility of increasing disability, means that a diagnosis can have substantial psychological consequences. OBJECTIVES: To assess the effectiveness of psychological interventions for people </summary><link rel='replies' type='application/atom+xml' href='http://neurology-healthcare.blogspot.com/feeds/114639974426814745/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=27204255&amp;postID=114639974426814745' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/114639974426814745'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/114639974426814745'/><link rel='alternate' type='text/html' href='http://neurology-healthcare.blogspot.com/2006/04/psychological-interventions-for.html' title=''/><author><name>my-healthcare</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-27204255.post-114639568536512202</id><published>2006-04-03T19:50:00.000-07:00</published><updated>2006-04-30T04:14:45.370-07:00</updated><title type='text'></title><summary type='text'>Intravenous secretin for autism spectrum disorder.   SourceCochrane Database of Systematic Reviews. (3):CD003495, 2005.   BACKGROUND: SecretinSecretin is a 27 amino-acid polypeptide produced in the intestine. Its role in gastrointestinal function is well described. There is a postulated role in decreasing immune responses in the gut lumen. Secretin receptors have also been demonstrated in the </summary><link rel='replies' type='application/atom+xml' href='http://neurology-healthcare.blogspot.com/feeds/114639568536512202/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=27204255&amp;postID=114639568536512202' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/114639568536512202'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/114639568536512202'/><link rel='alternate' type='text/html' href='http://neurology-healthcare.blogspot.com/2006/04/intravenous-secretin-for-autism.html' title=''/><author><name>my-healthcare</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-27204255.post-114639418392203594</id><published>2006-04-01T15:37:00.000-08:00</published><updated>2006-04-30T23:54:16.946-07:00</updated><title type='text'>Risperidone in autism.</title><summary type='text'>Long-term effects of risperidone in children with autism spectrum disorders: a placebo discontinuation study.SourceJournal of the American Academy of Child &amp; Adolescent Psychiatry. 44(11):1137-44, 2005 Nov.OBJECTIVE: The short-term benefit of risperidone in ameliorating severe disruptive behavior in pediatric patients with autism spectrum disorders is well established; however, only one </summary><link rel='replies' type='application/atom+xml' href='http://neurology-healthcare.blogspot.com/feeds/114639418392203594/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=27204255&amp;postID=114639418392203594' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/114639418392203594'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/27204255/posts/default/114639418392203594'/><link rel='alternate' type='text/html' href='http://neurology-healthcare.blogspot.com/2006/04/risperidone-in-autism.html' title='Risperidone in autism.'/><author><name>my-healthcare</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry></feed>
